{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034647","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.343242+00:00","generated_at":"2026-05-31T06:47:22.586985+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Propanc Biopharma enters $85K AUD loan from board member for working capital","bullets":["Effective August 26, 2024, company entered loan agreement with a board member for $85,000 AUD.","Loan has no maturity date or interest rate; repayment at company's discretion.","Proceeds used for general working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034647","json":"https://secwatch.observer/filing/0001493152-24-034647.json","markdown":"https://secwatch.observer/filing/0001493152-24-034647.md","text":"https://secwatch.observer/filing/0001493152-24-034647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224034647/0001493152-24-034647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224034647/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:47:22.586985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}